Clinical Trial Update: Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) [Phase 2]

View source ↗

Summary

A Phase 2 feasibility study (FORTE) investigated retinoic acid as a treatment for emphysema; the trial has completed, with results not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• All-trans retinoic acid (ATRA) (all-trans retinoic acid)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Emphysema, Lung Diseases | Phase 2 | Status: COMPLETED